Compounding pharmacy should face deeper DEA investigation, says Rep. Markey

Mark Rockwell Top Priority Sector:  federal_agencies_legislative Image Caption:  Meningitis outbreak The company that made the pain relieving steroid at the center of a growing fungal meningitis outbreak should face a deeper investigation into its activities with federally-controlled drugs, said a U.S. lawmaker. Homepage position:  10 read more View full post on Government Security News

View full post on The Cyber Wars